ghk-cu and c60 400 mgVeganNon GMOLab TestedIn House VerifiedEnriched with copper peptides GHK-Cu Scalp Solution | Empower
Description
A large-scale real-world patient experience trial involving over 500 patients further corroborated these findings, with patients reporting a 32% decrease in overall pain ratings and a significant reduction in their reliance on standard neuropathic pain medications
PMID: 25415472
It is reasonable to assume that changes in CpG methylation levels in this region may reflect on the epigenetic landscape, possibly favoring the expression of CCL11
doi: 10.1097/00007890-200009270-00006
